Homeopathic Drug Proving Trial
Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Feb 2, 2010
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Medical doctors or medical students
- • Not being treated for any acute or chronic diseases on the day of inclusion
- • Written informed consent.
- Exclusion Criteria:
- • Pregnant women or nursing mothers
- • Homeopathic treatment over the previous six weeks
- • Participation in another clinical trial during the last six months
- • Anyone with a personal or professional dependence on the study physician or sponsor
- • Anyone who has been placed in hospital or other institution by authorities or decree
About Charite University, Berlin, Germany
Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berlin, , Germany
Patients applied
Trial Officials
Claudia M Witt, Prof, MD, MBA
Principal Investigator
Charité University Berlin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials